Formononetin ameliorates airway inflammation by suppressing ESR1/NLRP3/Caspase-1 signaling in asthmaBiomedicine & PharmacotherapyNovember 2, 202310.1016/j.biopha.2023.115799Cited by 42SaveCiteExport RISWatch citationsRelated PapersNo related papers foundPowered by citation graph analysis